The number of people with susceptibility test result for rifampicin in Guinea-Bissau
Guinea-Bissau: The number of people with susceptibility test result for rifampicin was 89.04 in 2021. ◆ Volatile
Latest (2021)
89.04
Change on year
up 55.1%
World rank
70th
of 146 countries
All-time high
89.04
in 2021
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Guinea-Bissau, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Guinea-Bissau stood at 89.04. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 55.1% on the previous year.
Guinea-Bissau ranks 70th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Guinea-Bissau, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 2.83 | — |
| 2019 | 0.8616 | -69.5% |
| 2020 | 57.41 | +6563.4% |
| 2021 | 89.04 | +55.1% |
Guinea-Bissau compared with similar countries
- Guinea-Bissau's 89.04 is above the median for low income countries, which is 37.16, 2.4× the median. (13 countries reporting)
- Guinea-Bissau's 89.04 is above the median for Sub-Saharan Africa, which is 61.16, 1.5× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.23 | 0 | 2.83 | 3 |
| 2020s | 73.23 | 57.41 | 89.04 | 2 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,070 deaths per 1,000 people (2090)
- Number of infants who die before age 1 941 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.899 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0664 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.8987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Guinea-Bissau?
- The number of people with susceptibility test result for rifampicin in Guinea-Bissau was 89.04 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Guinea-Bissau?
- The highest recorded value was 89.04 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Guinea-Bissau?
- The lowest recorded value was 0 in 2017.
- How does Guinea-Bissau rank for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 70th out of 146 countries with data for 2021.
- Where does this Guinea-Bissau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).